Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Bioorg Med Chem. 2012 Jul 5;20(17):5290–5295. doi: 10.1016/j.bmc.2012.06.030

Table 3.

NMR data of 13-hydroxy dechlorofontonamide (3) in CDCl3

Position δC, mult.a δH mult. (J in Hz)b COSYb HMBCb NOESYb
1 11.67 s 2 2
2 159.9, CH 8.47 s 1 8 1
3 188.9, C
4 153.7, C
5 118.8, CH 7.19 d (8.2) 6 7, 9, 16 17
6 135.3, CH 7.51 t (8.2) 5, 7 4, 8 5
7 119.3, CH 8.59 d (8.2) 6 5
8 140.8, C
9 117.7, C
10 133.6, C
11 144.5, CH 7.10 d (2.4) 15 3, 10, 13, 15, 20 19
12 44.0, C
13 64.8, CH 4.05 dd (12.8, 3.4) 14eq, 14ax 14, 15, 19, 20 14eq, 15, 20
13-OH 1.54 s
14eq 30.8, CH2 2.32 ddd (12.8, 6.0, 3.4) 13, 14ax, 15 10, 12, 13 13, 15, 17
14ax 2.09 q (12.8) 13, 14eq, 15 12, 13, 16 18, 19
15 44.2, CH 2.82 ddd (12.8, 6.0, 2.4) 14eq, 14ax 11, 14, 16, 18 13, 17
16 37.8, C
17 24.2, CH3 1.44 s 4, 15, 16, 18 5
18 25.4, CH3 1.04 s 4, 15, 16, 17
19 19.9, CH3 1.35 s 11, 12, 13, 20 11, 20, 21Z
20 142.9, CH 5.92 dd (17.4, 10.7) 21E, 21Z 11, 12, 13, 19 19
21E 115.1, CH2 5.20 d (10.7) 20 12, 13 c
21Z 5.18 d (17.4) 20 12, 20 19
a

Chemical shifts determined from gHSQC and gHMBC experiments recorded at 600 MHz.

b

Recorded at 600 MHz.

c

A four-bond correlation resulting from “W” configuration.